InsiderPresident, R&D

Donald A Bergstrom Insider Trading Activity

Every SEC Form 4 transaction reported by Donald A Bergstrom, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · Insider-trading data from SEC EDGAR
Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Donald A Bergstrom buying or selling?

Donald A Bergstrom reported 0 open-market buys ($0) and 53 sells ($12.1M) across 53 Form 4 filings at 1 company — a net selling position of $12.1M.

Source: SEC EDGAR Form 4

What stands out

  • All 53 of Donald A Bergstrom's Form 4 filings are for one company, Relay Therapeutics, Inc. (RLAY).
  • The most recent Form 4 was accepted on Sep 9, 2026 (39 days ago).
  • In the last 12 months: no open-market purchases and 7 sales ($2.4M).
  • The largest open-market sale in the last 12 months was $1.6M of Relay Therapeutics, Inc. (RLAY) on Jun 24, 2026. SEC ↗

Key Statistics (as of Sep 9, 2026)

Total Form 4 filings
53
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (53)
$12.1M

Insider sentiment

Net selling

Net insider flow of $12.1M in net selling, filed between Apr 20, 2021 – Sep 9, 2026.

Companies Donald A Bergstrom files for

#CompanyForm 4 filings
1RLAYRelay Therapeutics, Inc.53

Recent Donald A Bergstrom transactions

DateTickerRoleTypeSharesValueFiling
Sep 9, 2026RLAYPresident, R&DSale8.5K$161.8KSEC ↗
Jul 30, 2026RLAYPresident, R&DSale2.2K$41.6KSEC ↗
Jul 8, 2026RLAYPresident, R&DSale8.7K$162.0KSEC ↗
Jun 24, 2026RLAYPresident, R&DSale93.5K$1.6MSEC ↗
Apr 30, 2026RLAYPresident, R&DSale1.5K$22.0KSEC ↗
Jan 29, 2026RLAYPresident, R&DSale21.6K$166.7KSEC ↗
Oct 30, 2025RLAYPresident, R&DSale30.9K$225.2KSEC ↗
Jul 30, 2025RLAYPresident, R&DSale30.8K$113.5KSEC ↗
May 1, 2025RLAYPresident, R&DSale31.6K$95.4KSEC ↗
Mar 31, 2025RLAYPresident, R&DSale986$2.8KSEC ↗
Jan 31, 2025RLAYPresident, R&DSale80.5K$362.3KSEC ↗
Dec 31, 2024RLAYPresident, R&DSale657$2.9KSEC ↗
Oct 30, 2024RLAYPresident, R&DSale2.7K$16.3KSEC ↗
Oct 1, 2024RLAYPresident, R&DSale648$4.9KSEC ↗
Jul 31, 2024RLAYPresident, R&DSale2.7K$23.9KSEC ↗
Jul 1, 2024RLAYPresident, R&DSale648$4.1KSEC ↗
Apr 30, 2024RLAYPresident, R&DSale2.7K$17.1KSEC ↗
Mar 29, 2024RLAYPresident, R&DSale765$5.9KSEC ↗
Jan 31, 2024RLAYPresident, R&DSale3.2K$30.6KSEC ↗
Dec 29, 2023RLAYPresident, R&DSale977$11.2KSEC ↗
Nov 1, 2023RLAYPresident, R&DSale3.5K$20.8KSEC ↗
Sep 29, 2023RLAYPresident, R&DSale648$5.4KSEC ↗
Jul 31, 2023RLAYPresident, R&DSale2.7K$31.7KSEC ↗
Jun 28, 2023RLAYPresident, R&DSale647$7.8KSEC ↗
Jun 1, 2023RLAYPresident, R&DSale2.9K$31.8KSEC ↗

Showing the 25 most recent filings of 53. Screen every filing.

Donald A Bergstrom insider trading FAQ

Is Donald A Bergstrom buying or selling?

Across 53 SEC Form 4 filings, Donald A Bergstrom reported 0 open-market purchases totaling $0 and 53 sales totaling $12.1M — a net selling position of $12.1M.

Which companies does Donald A Bergstrom file Form 4s for?

Donald A Bergstrom has reported insider transactions at 1 company, most often Relay Therapeutics, Inc. (RLAY).

How far back does Donald A Bergstrom's filing history go?

Trabud holds Donald A Bergstrom's SEC Form 4 filings from Apr 20, 2021 – Sep 9, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Donald A Bergstrom's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track Donald A Bergstrom and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener